Timp3, or tissue inhibitor of metalloproteinases-3, has been found to inhibit angiogenesis through a VEGF mediated pathway [44], and has been found to be silenced through promoter hypermethylation in a variety of tumor types [45], [46], [47], [48]. This evidence concerns the gene VEGFA and neoplasm.